Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
10.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.0201
|
0.07
|
0.0201
|
0.0201
|
0.0201
|
0.0201
|
|
|
18.14
|
3.00
|
0.0201
|
0.07
|
0.020601
|
0.0201
|
0.024301
|
0.0201
|
|
|
499.43
|
12.00
|
0.0201
|
0.07
|
0.020501
|
0.020501
|
0.020501
|
0.020501
|
|
|
10.25
|
2.00
|
0.0201
|
0.07
|
0.0207
|
0.0205
|
0.0207
|
0.0205
|
|
|
43.31
|
5.00
|
0.0201
|
0.07
|
0.02205
|
0.0201
|
0.02205
|
0.021
|
|
|
1 076.84
|
13.00
|
0.0201
|
0.028
|
0.025
|
0.025
|
0.028
|
0.028
|
|
|
426.90
|
8.00
|
0.0201
|
0.023
|
0.0251
|
0.0226
|
0.0251
|
0.0228
|
|
|
34.60
|
8.00
|
0.0156
|
0.0288
|
0.0212
|
0.021
|
0.029
|
0.0288
|
|
|
655.55
|
31.00
|
0.0201
|
0.08
|
0.0304
|
0.022
|
0.0338
|
0.029
|
|
|
1 038.54
|
23.00
|
0.0201
|
0.07
|
0.03
|
0.03
|
0.04
|
0.0385
|
|
|
405.32
|
8.00
|
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs known as selective translation regulator inhibitors (STRIs).